BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by unconsolidated joint ventures, BXP's portfolio totals 53.3 million square feet and 185 properties, including seven properties under construction/redevelopment.

BXP, Inc.

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) just unveiled an announcement. Botanix Pharmaceuticals has disclosed a change in director Vincent Ipp...

Botanix Director Increases Equity Stake via Performance Rights Conversion

The latest announcement is out from Botanix Pharmaceuticals Limited ( ($AU:BOT) ). Botanix Pharmaceuticals has applied for quotation on the ASX of ...

Botanix seeks ASX quotation for 24.9 million new shares

The latest update is out from Beximco Pharmaceuticals Limited Sponsored GDR RegS ( ($GB:BXP) ). Beximco Pharmaceuticals PLC has issued a clarificat...

Beximco Pharma Clarifies Board Restructuring Reports Amid Ongoing BSEC Dispute

BXP ( ($BXP) ) has shared an announcement. On August 31, 2026, Boston Properties Limited Partnership completed the issuance and sale of $700 millio...

BXP Issues New Senior Notes to Refinance Debt

The latest update is out from BXP ( ($BXP) ). On August 31, 2026, Boston Properties Limited Partnership completed a $700 million offering of 6.050%...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BXP	$63.40	+1.81%	1.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BXP	$63.40	+1.8%	1.02M
3
4
5
6

BXP

Get BXP, Inc. Data in Excel

Get BXP, Inc. Data in Excel